Mass General/North Shore Cancer Center — Danvers, Massachusetts

Mass General/North Shore Cancer Center is a clinical research site located in Danvers, Massachusetts, United States 01923.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Mass General/North Shore Cancer Center has participated in 26 clinical trials with 12 currently active.

Therapeutic areas: Prostate Cancer, Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor.

Sponsors: Radiation Therapy Oncology Group, ETOP IBCSG Partners Foundation, Alliance for Clinical Trials in Oncology.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Mass General/North Shore Cancer Center?

Mass General/North Shore Cancer Center has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Mass General/North Shore Cancer Center conducted?

Mass General/North Shore Cancer Center has 26 clinical trials on record, with 12 currently active. Their work covers Prostate Cancer, Estrogen Receptor Positive Breast Cancer, Progesterone Receptor Positive Tumor.

Is Mass General/North Shore Cancer Center accredited by Crixeo Health?

Yes — Mass General/North Shore Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Mass General/North Shore Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.